Literature DB >> 3477649

Mast cell involvement in interstitial cystitis.

W L Lynes1, S D Flynn, L D Shortliffe, M Lemmers, R Zipser, L J Roberts, T A Stamey.   

Abstract

A prospective study was designed to examine the relationship of mast cells, and eosinophilic leukocyte density and mediator levels to clinical and histological parameters of interstitial cystitis. Interstitial cystitis and control patients underwent bladder biopsy with histological examination, and quantification of intact and degranulated mast cell and eosinophilic leukocyte density. In addition, bladder tissue histamine content, urinary prostaglandin E2 excretion rates, and serum and urinary major basic protein levels were determined. A strong relationship among detrusor mast cell density, especially degranulated, and degree of epithelial loss, submucosal inflammation, epithelial ulceration, urinary pyuria and response to treatment was noted. Bladder tissue histamine content and urinary prostaglandin E2 excretion were increased in the interstitial cystitis patients. Eosinophil density in bladder biopsies was low uniformly, and interstitial cystitis and control patients showed no statistical difference. In addition, serum and urinary major basic protein levels were below the accepted normal lower limits for this protein. Therefore, our study demonstrates a relationship between the mast cell and the inflammatory process of interstitial cystitis. No similar relationship was noted for the eosinophil.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3477649     DOI: 10.1016/s0022-5347(17)43359-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

1.  Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis.

Authors:  R Saban; M R Saban; N B Nguyen; B Lu; C Gerard; N P Gerard; T G Hammond
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  Pathology, pathophysiology, and pathogenesis of painful bladder diseases.

Authors:  M Holm-Bentzen
Journal:  Urol Res       Date:  1989

Review 3.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

4.  Low-molecular-weight inhibitor of in vitro fibroblast colony formation from human urine.

Authors:  B W Steinert; J E Robinson; B A Mitchell; A C Diokno
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Post-irradiation bladder dysfunction: development of a rat model.

Authors:  J A Vale; W G Bowsher; K Liu; A Tomlinson; H N Whitfield; K R Trott
Journal:  Urol Res       Date:  1993

Review 6.  Etiology: where does prostatitis stop and interstitial cystitis begin?

Authors:  Evan R Eisenberg; Robert M Moldwin
Journal:  World J Urol       Date:  2003-05-28       Impact factor: 4.226

7.  Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis.

Authors:  Omer Kutlu; Erdem Akkaya; Ismail Turker Koksal; Ibrahim Cumhur Bassorgun; Mehmet Akif Ciftcioglu; Salih Sanlioglu; Erdal Kukul
Journal:  Int Urol Nephrol       Date:  2009-08-25       Impact factor: 2.370

8.  A model for the function of glycosaminoglycans in the urinary tract.

Authors:  C L Parsons
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.

Authors:  Zun-Yi Wang; Peiqing Wang; Dale E Bjorling
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-12       Impact factor: 3.619

10.  Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.

Authors:  Birthe Schnegelsberg; Tung-Tien Sun; Gary Cain; Anindya Bhattacharya; Philip A Nunn; Anthony P D W Ford; Margaret A Vizzard; Debra A Cockayne
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-23       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.